TechNavio recognizes the following companies as the key players in the Global Biophotonics Market: Affymetrix Inc., Andor Technology plc, Becton, Dickinson & Co., Carl Zeiss MicroImaging GmbH, Hamamatsu Photonics KK, and Olympus America Inc.
Commenting on the report, an analyst from TechNavio’s team said: “The diagnostic techniques which make use of biophotonics are expanding in terms of the variety of applications in various fields. As far as microscopy and other associated technologies are concerned, biophotonics is used to detect biological functions at cellular and sub-cellular levels. Biophotonics is also beginning to play a significant role in Food Sciences sector for ensuring food safety, where the technology is being utilized in infrared and mass spectroscopy to detect pollutants in foodstuffs. Biophotonics-based imaging technology is also finding increasing use in various fields of study, including nanobiotechnology and cell biology. Further, it is expected in the near future that biopsies and existing mechanical scanning equipment will be replaced by biomedical imaging. Moreover, biophotonics is now being used in live cell imaging, which is used for the study of protein expression, protein-to-protein interactions, and localization. In addition, biophotonics therapy has been accepted as a useful means for palliative care and for treating cancer during the early stages. Also, coherence optical tomography has transformed the field of ophthalmology by allowing the early diagnosis of macular degeneration in the retina, while photodynamic therapy methods have been developed for the treatment of cancer that act by delaying the growth of new blood vessels and vasculature.”
According to the report, one of the major drivers in this market is the steadily growing aging population worldwide. Biophotonics enables faster detection and optimum treatment of critical illnesses. The number of patients suffering from critical illnesses is growing owing to the increase in the aging population, both in developing and developed nations.
Further, the report states that one of the major challenges faced by the market is the high cost of biophotonics instruments. Various small end-users do not have the required budget to be able to capitalize on high-end research instruments and hence settle for low-cost alternatives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/global-biophotonics-market-2012-2016
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Global Biophotonics Market 2012-2016
